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Our results suggest that ampicillin, chloramphenicol 
and trimethoprim-sulfamethoxazole should no longer 
be the antibiotics of choice for shigella infections. The 
resistance rates of Salmonella serogroups favor the use 
of quinolones in enteric fever. However, although the 
MIC90 values of quinolones for Shigella strains are stdl 
between 0.008 and 0.06 mg/L, the same values for 
Salmonella typhi and Salmonella serogroup B are higher 
(0.25--1mg/L), suggesting that there might be quino- 
lone-resistant Salmonella isolates in the near future. 
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Clinical impact of changing to an automated blood-culture 
system at a small community hospital 
Clin Microbiol Infect 1999; 5: 590-593 
Automated, near-continuous-monitoring blood-culture 
systems provide several advantages to clinical micro- 
biology laboratories, including shorter detection times, 
reduced rates of contaminant blood cultures, and a 
reduction in hands-on processing time, compared to 
manual blood-culture systems [ 1-41. However, the 
purchase of an automated system represents a significant 
expenditure for smaller hospitals. Additionally, the 
clinical impact and long-term cost-effectiveness of 
these systems have not been extensively studied. 
We investigated the clinical impact of a change 
from the Isolator system (Warnpole Laboratories, 
Cranbury, NJ, USA) to the Bactec 9240 automated 
blood-culture system (Becton Dickinson Diagnostic 
Instrument Systems, Sparks, MD, USA) at a 200-bed 
community hospital. In addition to comparing detec- 
tion times for bloodstream isolates, we reviewed charts 
to determine how early clinician notification of positive 
blood-culture results affected antibiotic utilization. We 
also compared rates of contaminant isolation during the 
use of each system, since blood-culture contaminants 
are recognized to increase costs [5] and are likely to 
contribute to the unnecessary use of glycopeptide 
antibiotics, perhaps contributing to the problem of 
glycopeptide resistance [6,7]. 
The Central Maine Medical Center is a 200-bed 
community hospital with a 16-bed intensive care unit 
and an active hematology-oncology service. The on- 
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site microbiology laboratory processes between 3000 
and 4000 blood cultures annually. In March 1997, the 
Isolator system was replaced with the Bactec 9240 
blood-culture system for all routine blood cultures. All 
blood cultures performed during the 3 month period 
before (1 December 1996 to 28 February 1997) and 
after (1 April 1997 to 30 June 1997) the Bactec system 
was implemented were examined. 
There was no change in the procedure for col- 
lection of blood cultures during the time of the study. 
Trained phlebotomists prepared a venipuncture site 
(usually antecubital) with povidone-iodine and allowed 
the solution to dry for at least 1 min prior to wiping 
again with a sterile alcohol pad. Ten milliliters of blood 
was obtained in sterile fashion for the Isolator tubes, 
and 17-20 mL. (if possible) for the Bactec vials (10 mL 
for the aerobic and 7 mL for the anaerobic vials). 
Almost invariably, two sets of blood cultures were 
obtained from each patient, separated by 15-30 min. 
The Isolator tubes were processed in the micro- 
biology laboratory according to the manufacturer’s 
instructions, and cultures were examined every morn- 
ing by the technologist. A biohazard hood was used in 
processing the Isolator cultures. Bactec bottles were 
loaded into the Bactec 9240 instrument immediately 
after receipt in the microbiology laboratory and incu- 
bated for 5 days with continuous agitation. 
AU positive cultures with the Isolator and positive 
signals from the Bactec system were evaluated with a 
Gram stain, and the results reported either to the order- 
ing physician or to the physician responsible for the 
patient at the time of the positive culture. Detection 
time was defined as the time from blood-culture collec- 
tion to the time at which the microbiology laboratory 
recorded reporting the positive culture result to the 
clinician. Only the first reported positive blood culture 
for each pathogen in each patient was examined. 
Because a significant reduction in mean detection 
time for all pathogens was noted after the switch to the 
Bactec system, a review of all charts for patients who 
were found to be bacteremic during this time was 
performed, in order to determine whether and how 
clinicians altered antibiotic therapy after early notifica- 
tion of a positive blood-culture result. An antibiotic 
change was considered to be a response to a positive 
blood-culture result only if it was made within 3 h of 
receiving this notification. Any change that broadened 
antibiotic therapy in the spectrum corresponding to the 
Gram-stain of the positive culture was considered to be 
adequate, unless the patient was clearly clinically im- 
proving and on an existing antibiotic regimen. Like- 
wise, any failure to change, add or initiate antibiotics 
within the spectrum of activity of the Gram-stain result 
was considered to be inadequate therapy. 
A positive blood culture was defined as a probable 
contaminant if the organism was a coagulase-negative 
Staphylococcus, Micrococcus, Corynebacterium or Bacillus 
species isolated &om a single blood culture where at least 
two blood cultures were collected for culture, and no 
other sterile site cultures grew the same organism. The 
charts &om cases in which contaminant status was un- 
clear were reviewed by the infectious diseases physician. 
Of 1674 blood cultures obtained during the study 
period, 195 (1 1.6%) were positive, representing 108 
bacteremias. Mean detection times were shorter for the 
Bactec system for all positive cultures, all probable 
pathogens, all Gram-positive pathogens, and all Gram- 
negative pathogens (see Table 1). 
Review of patient charts for all bacteremias during 
the use of the Bactec system (N=40) revealed that 
clinicians altered antibiotic use within 3 h of notifica- 
tion of a positive blood-culture result in 18 cases 
(45%). In over half of the cases in which antibiotic 
therapy was altered, the change involved the addition 
of vancomycin for Gram-positive cocci or an 
aminoglycoside for Gram-negative rods. In over 85% of 
cases (35 of 40), the clinician response to notification 
of a positive blood-culture result was judged to be 
adequate (for example, either the patient was already on 
appropriate therapy, or the therapy was altered within 
3 h to strengthen coverage within the spectrum of 
activity of the Gram stain result). 
Rates of detection of pathogens by species did not 
differ between the two time periods, but there was a 
statistically significantly higher rate of isolation of 
probable contaminants with the Isolator system (2.7% 
versus 0.7%, P=O.OOl). Given that over 3000 blood 
cultures are processed annually at our institution, the 
higher rate of contaminant isolation we experienced 
when using the Isolator system represents over 60 
additional contaminants per year in our hospital. 
We believe that the use of the Bactec 9240 
automated blood-culture system has improved the 
management of bacteremia at our 200-bed community 
hospital by allowing for early antibiotic alteration in 
patients with bacteremia. Previous studies have demon- 
strated a favorable impact of early antibiotic suscept- 
ibility reporting on clinical management and cost [8,9]. 
However, the impact of earlier detection and reporting 
of positive blood cultures (without identification and 
susceptibility information) has not been as extensively 
investigated. 
Weinstein et al [lo], in a review of 843 episodes 
of positive blood cultures, reported lower mortality for 
those patients in whom antibiotic therapy was 
appropriately altered at the time of blood-culture 
positivity, when compared to patients in whom appro- 
priate therapy was administered only after suscep- 
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Table 1 Comparison of mean detection times for Bactec versus Isolator blood culture systems 
Mean detection 
time (h) (median) 
Microorganisms Isolator Bactec Mean Merence (h) P' 
AU positive cultures 51.9 22.2 29.7 <0.001 
AU probable pathogens 45.5 20.7 24.8 <0.001 
Gram-positive pathogens 42.6 21.9 20.7 0.001 
Staphylococcus dureus 41.1 11.8 29.3 0.002 
(43.6) (16.4) 
(39.7) (15.0) 
(39.4) (17.0) 
(46.4) (12.0) 
Streptococlus spp. 39.5 14.7 24.8 0.013 
(32.0) (17.0) 
Gram-negative pathogens 35.0 14.1 20.9 0.003 
Entero bacteriaceae 29.2 15.1 14.1 0.002 
(34.6) (12.5) 
(34.6) (12.5) 
Two sample t-test. AU P-values are two-sided. 
tibility test results were available (13.3% versus 25.8% 
mortality). This suggests that the over 24-h reduction 
in detection times we describe after the change to 
an automated, near-continuous-monitoring blood- 
culture system, combined with the rate at which 
clinicians altered antibiotic therapy at this early time 
point, should improve outcomes in our bacteremic 
patients. 
In addition to improving the clinical management 
of bacteremic patients, our switch to the Bactec 9240 
blood-culture system reduced rates of contaminant 
blood cultures. This should reduce overall patient care 
costs, including the costs and morbidities associated 
with unnecessary treatment with parented antibiotics. 
Bates et al [5] have reported that each contaminant 
blood culture increased total hospital charges by over 
$4000 at their institution. We cannot generalize these 
data, obtained in 1990 at a tertiary-care hospital, to our 
200-bed community hospital. Nonetheless, if our 
excess hospital charges per contaminant were even half 
of those reported by Bates et al, we would have 
experienced an annual reduction in patient care costs 
of over $125 000 due to decreased contaminant rates 
since the introduction of the Bactec system. This 
represents over three times the cost of implementing 
ths  automated blood-culture system at our institution. 
We therefore conclude that the change to a 
continuous-monitoring system at our small community 
hospital has been both clinically important and cost- 
effective. Further study is required to determine 
whether it has had any impact on patient outcomes. 
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